![Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy - Popovtzer - 2017 - Head & Neck - Wiley Online Library Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy - Popovtzer - 2017 - Head & Neck - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ab0f5522-86bf-41f1-b6f1-56cb25512e5c/hed24571-fig-0006-m.png)
Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy - Popovtzer - 2017 - Head & Neck - Wiley Online Library
![Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy - Popovtzer - 2017 - Head & Neck - Wiley Online Library Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy - Popovtzer - 2017 - Head & Neck - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/adfa0070-e6cd-42e6-a0f0-2e2a5dcab6fa/hed24571-fig-0002-m.jpg)